In breast cancer patients, miR-16–1-3p inhibits PGK1 expression by directly targeting its 30-untranslated region and represses breast cancer cell proliferation, migration, invasion, and metastasis by inhibiting the PGK1-mediated Warburg effect [60]. Here, PGK1 is linked to breast cancer.